Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Layton

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Hospital Medicine (London, England : 1998)|March 5, 2004
Systemic therapy for acne vulgarisAlison M Layton
Dermatologic Clinics|March 27, 2016
Top Ten List of Clinical Pearls in the Treatment of Acne VulgarisAlison M Layton
Clinics in Dermatology|March 10, 2017
Pharmacologic treatments for rosaceaAlison M Layton
American Journal of Clinical Dermatology|September 30, 2006
Persistent acne in women : implications for the patient and for therapyChristina Williams, Alison M Layton
The Lancet. Child & Adolescent Health|December 16, 2022
Adolescent acne vulgaris: current and emerging treatmentsAlison M Layton, Jane Ravenscroft
Expert Review of Clinical Pharmacology|November 25, 2011
Treating acne vulgaris: systemic, local and combination therapyLaura J Savage, Alison M Layton
Dermatology and Therapy|June 11, 2021
Updated Treatment for Acne: Targeted Therapy Based on PathogenesisIchiro Kurokawa, Alison M Layton, Rei Ogawa
Clinical, Cosmetic and Investigational Dermatology|March 6, 2023
Real-World Case Studies Showing the Effective Use of Azelaic Acid in the Treatment, and During the Maintenance Phase, of Adult Female Acne PatientsAlison M Layton, Marco Alexandre Dias da Rocha
American Journal of Clinical Dermatology|December 4, 2003
Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribersAnne E Eady, Jonathan H Cove, Alison M Layton
The Journal of Investigative Dermatology|January 16, 2014
IL-17: a key player in the P. acnes inflammatory cascade?Diane M Thiboutot, Alison M Layton, E Anne Eady
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Hospital Medicine (London, England : 1998)|March 5, 2004
Systemic therapy for acne vulgarisAlison M Layton
Dermatologic Clinics|March 27, 2016
Top Ten List of Clinical Pearls in the Treatment of Acne VulgarisAlison M Layton
Clinics in Dermatology|March 10, 2017
Pharmacologic treatments for rosaceaAlison M Layton
American Journal of Clinical Dermatology|September 30, 2006
Persistent acne in women : implications for the patient and for therapyChristina Williams, Alison M Layton
The Lancet. Child & Adolescent Health|December 16, 2022
Adolescent acne vulgaris: current and emerging treatmentsAlison M Layton, Jane Ravenscroft
Expert Review of Clinical Pharmacology|November 25, 2011
Treating acne vulgaris: systemic, local and combination therapyLaura J Savage, Alison M Layton
Dermatology and Therapy|June 11, 2021
Updated Treatment for Acne: Targeted Therapy Based on PathogenesisIchiro Kurokawa, Alison M Layton, Rei Ogawa
Clinical, Cosmetic and Investigational Dermatology|March 6, 2023
Real-World Case Studies Showing the Effective Use of Azelaic Acid in the Treatment, and During the Maintenance Phase, of Adult Female Acne PatientsAlison M Layton, Marco Alexandre Dias da Rocha
American Journal of Clinical Dermatology|December 4, 2003
Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribersAnne E Eady, Jonathan H Cove, Alison M Layton
The Journal of Investigative Dermatology|January 16, 2014
IL-17: a key player in the P. acnes inflammatory cascade?Diane M Thiboutot, Alison M Layton, E Anne Eady
Pageof 7